Analyzing ADB International Group (OTCMKTS:EQUR) and Neuronetics (NASDAQ:STIM)

Neuronetics (NASDAQ:STIM) and ADB International Group (OTCMKTS:EQUR) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk.

Insider and Institutional Ownership

53.6% of Neuronetics shares are held by institutional investors. 8.7% of Neuronetics shares are held by insiders. Comparatively, 79.6% of ADB International Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Neuronetics and ADB International Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Neuronetics	-33.88%	-131.15%	-31.26%
ADB International Group	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Neuronetics and ADB International Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1	0	1	0	2.00
ADB International Group	0	0	0	0	0.00

Neuronetics presently has a consensus target price of $7.00, suggesting a potential upside of 392.96%. Given Neuronetics’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Neuronetics is more favorable than ADB International Group.

Valuation & Earnings

This table compares Neuronetics and ADB International Group”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$74.89 million	1.30	-$43.71 million	($0.82)	-1.73
ADB International Group	N/A	N/A	N/A	N/A	N/A

ADB International Group has lower revenue, but higher earnings than Neuronetics.

Summary

Neuronetics beats ADB International Group on 5 of the 9 factors compared between the two stocks.

About Neuronetics

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.